To date, brain gene therapies require high vector doses. Here, authors devised an AAV capsid screen and found variants with unprecedented potency for transduction of deep brain and cortical neurons and human iPSC-neurons with cell tropism relevant for Huntington’s and Parkinson’s disease.
- D. E. Leib
- Y. H. Chen
- B. L. Davidson
